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Previous studies have shown that Foxc1 and Foxc2, closely related Fox transcription factors, have interactive roles in cardiovascular
development. However, little is known about their functional overlap during early heart morphogenesis. Here, we show that Foxc genes are
coexpressed in a novel heart field, the second heart field, as well as the cardiac neural crest cells (NCCs), endocardium, and proepicardium.
Notably, compound Foxc1; Foxc2 mutants have a wide spectrum of cardiac abnormalities, including hypoplasia or lack of the outflow tract (OFT)
and right ventricle as well as the inflow tract, dysplasia of the OFT and atrioventricular cushions, and abnormal formation of the epicardium, in a
dose-dependent manner. Most importantly, in the second heart field, compound mutants exhibit significant downregulation of Tbx1 and Fgf8/10
and a reduction in cell proliferation. Moreover, NCCs in compound mutants show extensive apoptosis during migration, leading to a failure of the
OFT septation. Taken together, our results demonstrate that Foxc1 and Foxc2 play pivotal roles in the early processes of heart development,
especially acting upstream of the Tbx1-FGF cascade during the morphogenesis of the OFT.
© 2006 Elsevier Inc. All rights reserved.Keywords: Heart development; Second heart field; Outflow tract; Neural crest; Epicardium; Cushion mesenchyme; ForkheadIntroduction
The mammalian heart is composed of four chambers with
multiple cell types such as myocardial and endocardial cells,
heart-valve mesenchyme, and endothelial and smooth muscle
cells of coronary blood vessels (Hutson and Kirby, 2003; Kirby,
2002; Reese et al., 2002). Heart morphogenesis begins with the
formation of the primitive tubular heart by fusion of the cardiac
crescent, which contains myocardial and endocardial progenitor
cells. Until recently, it was believed that the cardiac crescent
(the first heart field) gives rise to the myocardium and
endocardium of the entire heart tube. However, compelling
evidence has recently demonstrated the identification of a novel
heart field, the second heart field, thereby modifying the
classical concept of heart formation (Buckingham et al., 2005).
In addition, it is known that two types of extracardiac cell
populations, cardiac neural crest cells (NCCs) and epicardium-
derived cells (EPDCs), significantly contribute to the morpho-⁎ Corresponding author. Fax: +1 615 936 1872.
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doi:10.1016/j.ydbio.2006.06.012genesis of the developing heart (Hutson and Kirby, 2003; Kirby,
2002; Olivey et al., 2004; Wada et al., 2003). Compelling
evidence demonstrates that signaling pathways such as BMP
and FGF regulate early heart development (Brand, 2003;
Buckingham et al., 2005; Kelly and Buckingham, 2002; Kirby,
2002; Yutzey and Kirby, 2002) and that the combined activities
of different transcription factors modulate gene expression in
this process (Cripps and Olson, 2002; Kelly, 2005). Here we
show that the murine Foxc1 and Foxc2, closely related
forkhead/Fox transcription factors, play important roles in
early steps of the developing heart, including the formation of
the OFT.
Recent studies have shown that the myocardium and
endocardium of the OFT derive from a newly identified cell
population, the anterior heart field (AHF) or secondary heart
field (SHF) in the chick andmouse (Kelly et al., 2001;Mjaatvedt
et al., 2001; Waldo et al., 2001). This cell population originates
from the medial splanchnic mesoderm adjacent to the cardiac
crescent and then extends progressively to the pharyngeal region
anterior and dorsal to the arterial pole of the heart (Kelly and
Buckingham, 2002; Kelly, 2005). Subsequently, it has been
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more posteriorly in addition to the AHF in the mouse, and cells
expressing Isl1 contribute to both the arterial and venous poles
of the mouse heart (Cai et al., 2003). Retrospective clonal
analysis in the mouse has further reinforced the two heart
lineages with a common clonal origin of about 140 cardiac
progenitor cells (Meilhac et al., 2004). Although the first and
second lineages have, to a large extent, an overlapping
contribution to the right ventricle (RV), atrioventricular canal,
atria, and inflow tract (IFT) of the heart, the two lineages
exclusively form the left ventricle (LV) and OFT, respectively.
Notably, the second lineage gives rise to the second heart field as
defined by derivatives of Isl1-positive cells.
The perturbation of the second heart field by disrupting the
functions of signaling pathways or cardiac transcription factors
leads to conotruncal defects such as persistent truncus
arteriosus, as well as myocardial dysfunction (Kelly, 2005).
For example, BMP and FGF signaling is involved in the
development of the OFT through the recruitment and
differentiation of myocardial precursors derived from the
anterior part of the second heart field (Kelly and Buckingham,
2002; Kirby, 2002). Mice lacking both Bmp4 and Bmp7 have a
shortened OFT with hypoplastic cushions (Liu et al., 2004),
whereas hypomorphic mutants for Fgf8 have defects in the OFT
septation along with abnormal formation of the forth pharyngeal
arch artery (PAA) and increased apoptosis of migrating NCCs
(Frank et al., 2002).
Analysis of Isl1-deficient mice lacking the OFT and RV
suggests that Isl1 regulates proliferation, migration, and
survival of the second heart field-derived cells through FGF
and BMP signaling (Cai et al., 2003). Myocyte enhancer factor
2c (Mef2c) null mutants display lack of RVas well as hypolastic
OFT and IFT (Lin et al., 1997). Importantly, activity of Mef2c
enhancer, which directs its expression in the second heart field
as well as OFT and RV, is dependent on Gata-4 and Isl1,
suggesting that Mef2c is a direct target of these transcription
factors (Dodou et al., 2004). Foxh1mutant embryos fail to form
the OFT and RV with significant downregulation of Fgf8 and
Fgf10 in the second heart field-derived cells (von Both et al.,
2004). Tbx1, a member of T-box transcription factor family, is a
putative causative gene for DiGeorge syndrome associated with
an interstitial deletion of chromosome 22q11 in human, and has
been implicated in the development of the pharyngeal arch
arteries and the OFT septation (Merscher et al., 2001; Vitelli et
al., 2002). A recent study using conditional Tbx1 mutants
indicates that Tbx1 is required for cell proliferation in the
second heart field through Fgf10 signaling (Xu et al., 2004).
Cardiac NCCs originating from rhombomeres 6, 7, and 8 in
the dorsal neural tube have been shown to migrate into the heart
through the third, fourth, and sixth pharyngeal arches. While
this cell population forms the tunica media of all the great
arteries, a subpopulation of this cell type further migrates into
the OFT cushions by embryonic day 10.5 (E10.5) in the mouse
and then participates in the septation of the OFT into the aorta
and pulmonary trunk from E11.5 to E13.5 (Epstein et al., 2000;
Gitler et al., 2003a; Hutson and Kirby, 2003). Cardiac NCCs are
also indirectly involved in multiple processes of the developingheart (Hutson and Kirby, 2003; Jiang et al., 2000; Waldo et al.,
1998). In particular, ablation of the cardiac neural crest in the
chick results in primary myocardial dysfunction and the failure
to elongate the OFT myocardium derived from the second heart
field (Yelbuz et al., 2002, 2003), possibly because the cardiac
neural crest alters the availability of FGF8 in the pharynx
(Farrell et al., 2001). Recent studies further support the
importance of the cardiac NCCs on the addition of the OFT
myocardium, although they do not affect smooth muscle
differentiation in the OFT (Waldo et al., 2005a,b).
The proepicardium (PE), another extracardiac cell popula-
tion, is initially formed as a mesothelial primordium located on
the pericardial side of the septum transversum, and cells from
the PE migrate into the heart in which they form the epicardium.
Some of the epicardial cells subsequently undergo a process of
epithelial–mesenchymal transformation (EMT) to become
epicardium-derived cells (EPDCs), which subsequently differ-
entiate into endothelial and smooth muscle cells of coronary
blood vessels and cardiac fibroblasts, and also provide signaling
molecules to the ventricular myocardium (Kirby, 2002; Manner
et al., 2001; Munoz-Chapuli et al., 2002; Olivey et al., 2004;
Perez-Pomares et al., 2002a; Reese et al., 2002). For example,
WT (Wilms' tumor)-1 transcription factor is expressed in the
epicardium and mutant mice for WT-1 display abnormalities in
the epicardium formation with a reduced number of subepi-
cardial mesenchymal cells (Moore et al., 1999). However, the
precise molecular and cellular mechanisms underlying epicar-
dial EMT are still poorly understood.
We and others have previously shown that murine Foxc1 and
Foxc2, closely related forkhead/Foxc transcription factors, are
implicated in cardiovascular development (Iida et al., 1997;
Kume et al., 2001; Seo et al., 2006; Winnier et al., 1999;
Yamagishi et al., 2003). Foxc1 and Foxc2 have similar
expression patterns in many embryonic tissues, including
endothelial and mesenchymal cells of the developing heart
and blood vessels (Hiemisch et al., 1998; Iida et al., 1997;
Kume et al., 2001; Seo et al., 2006; Winnier et al., 1999). Foxc1
and Foxc2 are also expressed in the ectomesenchyme and
endocardial cushions derived from cardiac NCCs (Gitler et al.,
2003a; Winnier et al., 1999). Moreover, we show in this paper
that transcripts of Foxc1 and Foxc2 are detected in the second
heart field at the cardiac crescent stage (E7.75 in mouse), as well
as in the PE. Most compound Foxc1; Foxc2 heterozygotes, as
well as all single homozygotes, die pre- and perinatally with a
similar spectrum of cardiovascular defects such as the
interruption/coarctation of the aortic arch, ventricular septal
defects (VSDs), hypoplasia of semilunar valves, and thin
myocardium (Winnier et al., 1999). Compound Foxc1; Foxc2
homozygous mutants die much earlier with much more severe
cardiovascular defects than single Foxc null mutants (Kume et
al., 2001), suggesting that they have overlapping, dose-
dependent roles during cardiovascular development. However,
cooperative functions of Foxc genes in the early development
of the heart, including their role in the second heart field, remain
to be elucidated. Here, we demonstrate that compound Foxc1;
Foxc2 mutant embryos have numerous cardiac abnormalities,
including hypoplasia of the OFT. Therefore, we propose that
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heart development.
Materials and methods
Breeding mutant mice and genotyping of embryos
Generation and genotyping of compound heterozygous mice for Foxc1
and Foxc2 were performed as previously described (Kume et al., 1998,
2001), while they have been crossed with outbred ICR mice. Noon of the
day of plug was E0.5. To determine the phenotypes of compound Foxc1;
Foxc2 mutant embryos, we used at least two embryos of each genotype,
and the number of the somites was used for staging and matching wild-
type and mutant embryos. Since compound homozygous mutants do not
form any somites, wild-type embryos with a similar size were used for
comparison.
Histological analysis
Embryos (E8.5–E11.5) were fixed in 4% paraformaldehyde, dehydrated
through a series of methanol, embedded in paraffin, and sectioned at 8 μm.
The sections were used for hematoxylin/eosin staining, section in situ
hybridization, or immunohistochemistry as previously described (Kume et al.,
2001; Seo et al., 2006). The embryos were also used for whole mount in situ
hybridization.
Whole mount and section in situ hybridization
Whole-mount RNA in situ hybridization was performed using digox-
igenin-UTP (Roche) labeled probes and anti-digoxigenin-AP antibody (Roche)
as described previously (Kume et al., 2000a,b). Double RNA in situ
hybridization was carried out using digoxigenin-labeled Isl1 and fluorescein-
labeled Foxc1 riboprobes, and anti-digoxigenin-AP and anti-fluorescein-AP
antibodies, respectively. Staining reactions were performed with NBT-BCIP
(Roche) for Isl1 and INT-BCIP (Roche) for Foxc1 according to the Claudio
Stern's lab protocol (http://sternlab.anat.ucl.ac.uk/INSITU.htm). Radioactive
section in situ hybridization was performed using riboprobes labeled with
[α-35S] UTP (PerkinElmer Life and Analytical Sciences) as described
previously (Kume et al., 2001; Seo et al., 2006). Specific riboprobes used
for whole-mount or radioactive in situ hybridization are described in
Supplemental material.
Cell proliferation and TUNEL assays
Cell proliferation assays were performed by 5-bromo-2′-deoxyuridine
(BrdU) incorporation. Pregnant female mice were injected intraperitoneally
with 100 μg/g body weight of BrdU (Sigma) in PBS and sacrificed 2 h after
injection to collect embryos. Paraffin sections were subject to antigen
retrievals using Retrievit 6 (InnoGenex) in the microwave oven and then
incubated with mouse monoclonal anti-BrdU antibody (Sigma). Following
incubation with goat biotinylated anti-mouse IgG (Vector Laboratories),
detection of BrdU-incorporated cells was performed using peroxidase-
conjugated Vectastain Elite ABC kit (Vector Laboratories) and DAB substrate
(Chemicon International) according to the manufacturer's instructions. For
detection of apoptotic cells, the terminal deoxy-nucleotidyl transferase-
mediated biotinylated UTP nick end labeling (TUNEL) assays were carried
out on paraffin sections using ApopTag Plus Peroxidase In Situ Apoptosis
Detection Kit (Chemicon International), followed by detection by peroxidase-
conjugated Vectastain Elite ABC kit and DAB substrate according to the
manufacturer's instruction. The sections were counterstained with 0.5%
methyl green. For detection of AP2α and apoptosis, the sections were
incubated with a mouse monoclonal anti-AP2α antibody (Developmental
Studies Hybridoma Bank, The University of Iowa), followed by incubation
with secondary Alexa 488 goat anti-mouse IgG antibody (Molecular Probes)
for AP2α and TMR red In Situ Cell Death Detection reagents (Roche) for
simultaneous TUNEL.Immunohistochemical analysis
Paraffin sections were subject to antigen retrievals by heat-treatment for
30 min in antigen retrieval reagent Retrievit 6 (InnoGenex) in the microwave
oven for AP2α, BrdU, Isl1, α-SMA and WT-1 antibodies or by incubation with
0.025% trypsin for 8 min at 37°C for PECAM-1 antibody. The sections were
blocked for 20 min in PowerBlock (BioGenex) followed by incubation with
appropriate primary antibodies. After washing 3 times for 10 min in PBS/0.05%
Tween 20 (PBST), the sections were incubated with appropriate secondary
antibodies. Following extensive washes for 3 × 10 min in PBST, the sections
were counterstained with DAPI and mounted with anti-fading agent Gel/Mount
(Biomeda). α-SMA staining was performed using mouse anti-α-SMA (Sigma)
and Alexa 488 goat anti-mouse IgG (Molecular Probes) antibodies. WT-1
staining was done using mouse anti-human WT-1 (DAKO) and Alexa 488 goat
anti-mouse IgG (Molecular Probes) antibodies. For PECAM-1 staining, rat anti-
mouse CD31 (PECAM-1; BD Pharmingen) and rabbit biotinylated anti-rat IgG
(Vector Laboratories) antibodies were used as primary and secondary antibodies,
respectively. Detection was carried out using a peroxidase Vectastain Elite ABC
kit (Vector Laboratories) and DAB substrate (Chemicon International). For
double staining with rat monoclonal anti-BrdU (Abcam) and mouse monoclonal
anti-Isl1 (Developmental Studies Hybridoma Bank, The University of Iowa)
antibodies, antibody incubation was performed separately to avoid any possible
cross-reaction between rat anti-BrdU and mouse anti-Isl1 antibodies. The
secondary antibodies used were Alexa 568 goat anti-rat IgG (Molecular Probes)
for BrdU and Alexa 488 goat anti-mouse IgG for Isl1.
Results
Compound Foxc1; Foxc2 mutants have defects in the OFT, RV,
and IFT
Wehave previously shown that the twoFoxc genes play dose-
dependent, cooperative roles in cardiovascular development
(Kume et al., 2001; Seo et al., 2006; Winnier et al., 1999).
However, early cardiac defects in compound Foxcmutants have
not yet been described. Whereas compound Foxc1−/−; Foxc2−/−
mutants die around E9.5, compound Foxc1+/−; Foxc2−/− and
Foxc1−/−; Foxc2+/− mutants can survive until E12.0–12.5.
Therefore, we first performed extensive analysis of heart defects
in single Foxc mutants and compound Foxc1; Foxc2 mutant
embryos at E9.0 (∼19 somites) (Fig. 1 and data not shown). We
found that single mutants as well as compound Foxc1+/−;
Foxc2+/− and Foxc1−/−; Foxc2+/− mutants exhibited no obvious
abnormalities in the formation of the OFT and RVat E9.0 (data
not shown). Interestingly, compound Foxc1+/−; Foxc2−/−
mutants had a shortened OFT (Fig. 1B) and a smaller RV
(Fig. 1E) compared with the wild type. Moreover, compound
Foxc1−/−; Foxc2−/− mutants appeared to completely lack the
OFT and RV (Fig. 1F), resulting in direct connection of the
aortic sac to the ventricle (Fig. 1C). Recent cell lineage analysis
has suggested that the second lineage comprising Isl1-marked
cells contributes to both the arterial and venous poles of the
developing heart (Meilhac et al., 2004). Of note, compound
Foxc1+/−; Foxc2−/− mutants had a hypoplastic IFT (Fig. 1H),
while compound homozygotes appeared to lack the IFT (Fig.
1I), suggesting that Foxc1 and Foxc2 are required for the
formation of the arterial and venous poles of the developing
heart.
We also analyzed the phenotype of the OFT and RV in
compound Foxc1+/−; Foxc2−/− mutants at E10.5. The develop-
ing OFT divides into the distal and proximal components by a
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contrast, compound Foxc1+/−; Foxc2−/− mutants had hypoplas-
tic OFT and RV with a remarkable reduction in size (Figs. 1O,
Q). Strikingly, we found the lack of proximal OFT in compound
Foxc1+/−; Foxc2−/−mutants, although these mutants had a slight
reduction of the distal OFT in size. To further verify the OFT
defects observed in compound Foxc mutants, we examined
expression of Wnt11, which marks the OFT region (Cai et al.,
2003). At E9.0, the expression domain of Wnt11 wasFig. 1. Cardiac defects in compound Foxc1; Foxc2 mutants. (A–I) Histological analy
and Foxc1−/−; Foxc2−/− mutant (C, F, and I) embryos at E9.0 at the levels of the hea
(E), and IFT (H), while compound Foxc1−/−; Foxc2−/−mutant lacked the OFT (C), RV
ventricle in compound Foxc1−/−; Foxc2−/−mutant (C). Dashed lines demarcate the re
shows that Wnt11 expression was reduced in compound Foxc1+/−; Foxc2−/− mutan
(L, right view; M, front view), indicating the lack of OFT. (N–Q) Histological analys
and O) and sagittal (P and Q) sections at the level of the OFT. Compared to wild-type
of the OFT (O and Q) and IFT (Q). Note the lack of the proximal OFT in compound F
the expression domain of the OFT marker Wnt11 was significantly reduced in com
hypoplastic RV in compound Foxc1+/−; Foxc2−/−mutant at E11.5 (U), compared with
in the OFT. A, atrium; AS, aortic sac; IFT, inflow tract; LA, left atrium; LV, left ve
atrium; RV, right ventricle; V, ventricle. Scale bars, 100 µm.significantly reduced in compound Foxc1+/−; Foxc2−/− mutants
(Fig. 1K), whereas no expression was detected around the aortic
sac in compound Foxc1−/−; Foxc2−/− mutants (Figs. 1L, M),
suggesting that compound homozygotes completely lack OFT
identity. Consistent with these data, the expression domains of
Wnt11 were significantly reduced in compound Foxc1+/−;
Foxc2−/− mutants at E10.5 and E11.5 (Figs. 1S, U), indicating
that compound Foxc1+/−; Foxc2−/− mutants have hypoplastic
OFT. Taken together, our results demonstrate that Foxc1 andsis of wild-type (A, D, and G) and compound Foxc1+/−; Foxc2−/− (B, E and H)
rt. Compound Foxc1+/−; Foxc2−/− mutant embryo had hypoplastic OFT (B), RV
(F), and IFT (I). Note the direct connection of the disorganized aortic sac to the
gion of the aortic sac and OFT. (J–M)Whole-mount in situ hybridization at E9.0
t (K, right view), but absent in compound Foxc1−/−; Foxc2−/− mutant (arrows)
is of wild-type and Foxc1+/−; Foxc2−/− mutant embryos at E10.5. Transverse (N
embryos (N and P), compound Foxc1+/−; Foxc2−/−mutants exhibited hypoplasia
oxc1+/−; Foxc2−/−mutants. (R–U)Whole-mount in situ hybridization shows that
pound Foxc1+/−; Foxc2−/− mutants at E10.5 (S) and E11.5 (U). Note the very
the wild-type (T). Dotted lines (red) demarcate the expression domain ofWnt11
ntricle; OFT, outflow tract; dOFT, distal OFT; pOFT, proximal OFT; RA, right
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as well as the IFT during heart development.
Foxc1 and Foxc2 are required for the development of the
second heart field
Based on the severe cardiac defects in compound Foxc1+/−;
Foxc2−/− and Foxc1−/−; Foxc2−/− mutants, we examined
whether Foxc1 and Foxc2 are expressed in the second heart
field at the cardiac crescent stage by comparing known markers,
Fgf10, Isl1, and Tbx1 (Cai et al., 2003; Kelly et al., 2001;
Yamagishi et al., 2003). Whole mount in situ hybridization
showed that transcripts of both Foxc1 (Fig. 2D) and Foxc2 (Fig.
2E) are, to a large extent, overlapped with those of Isl1, Fgf10,
and Tbx1 (Figs. 2A–C). This observation is reinforced by
performing whole mount double in situ hybridization for Isl1
and Foxc1 (Fig. 2F). At E9.5 and E10.5, the expression of both
Foxc genes is also overlapped with that of Isl1 in the second
heart field (Supplementary Fig. 1). We next analyzed the
expression levels of markers for the second heart field in
compound Foxc1+/−; Foxc2−/− and Foxc1−/−; Foxc2−/− mutant
embryos at E8.5 (8 somites). Fgf8 is expressed in the splanchnic
mesoderm and OFT myocardium as well as in the pharyngeal
endoderm and ectoderm, but not in the pharyngeal mesoderm
(Cai et al., 2003). In compound Foxc1+/−; Foxc2−/− and
Foxc1−/−; Foxc2−/− mutants, Fgf8 expression was significantly
downregulated in the splanchnic mesoderm (Figs. 2H, I), while
its expression was unaffected in the pharyngeal endoderm and
ectoderm. Fgf10 is normally expressed in the pharyngeal
mesoderm, splanchnic mesoderm, and OFT myocardium
(Kelly et al., 2001; Cai et al., 2003). Transcripts of Fgf10 were
also downregulated in the pharyngeal mesoderm and splanchnic
mesoderm in compound Foxc1+/−; Foxc2−/− and Foxc1−/−;
Foxc2−/− mutants (Figs. 2K, L). Expression of Tbx1, a
downstream target of Foxc1 and Foxc2 in the head mesenchyme
(Yamagishi et al., 2003), was absent in the pharyngeal mesoderm
and splanchic mesoderm, but unaffected in the endoderm in
compound Foxc mutant embryos (Figs. 2N, O). It should be
noted that expression levels of these markers were more reduced
in compound homozygotes than in compound hetero/homo-
zygotes. Transcripts of Isl1 are normally detected in the
pharyngeal endoderm and splanchnic mesoderm as well as in
part in the pharyngeal mesoderm (Cai et al., 2003). In compound
Foxc1+/−; Foxc2−/− and Foxc1−/−; Foxc2−/− mutants, Isl1
expression was slightly reduced in the pharyngeal mesoderm
and splanchnic mesoderm, but remained unaffected in the
endoderm (Figs. 2Q, R). In addition, when Isl1-expressing cells
contribute to the OFT myocardium at E10.5 (Fig. 2S),
compound Foxc1+/−; Foxc2−/− mutants showed decreased Isl1
expression (Fig. 2T). Expression of Bmp4 and Bmp7 has been
shown to be reduced in Isl1 mutant embryos. In compound
Foxc mutants, transcripts of Bmp4 were partially reduced in
the second heart field and were restricted to the caudal region
of the OFT myocardium (Fig. 2V), whereas levels of Bmp7
expression did not appear to be altered in the OFT myo-
cardium (Fig. 2X). Of significant note, compound Foxc1+/−;
Foxc2−/− mutants showed a reduction in cell proliferation inthe Isl1-expressing cells at E10.5 (Fig. 2Z). Taken together,
these results suggest that Foxc1 and Foxc2 genes are important
regulators for the development of the second heart field.
NCCs undergo apoptosis in compound Foxc1; Foxc2 mutants
It has been known that cardiac NCCs contribute to the OFT
septation, thereby affecting the formation of the OFT (Creazzo
et al., 1998; Hutson and Kirby, 2003; Waldo et al., 1998). Given
that Foxc1 and Foxc2 are expressed in cardiac NCCs (Iida et
al., 1997; Kume et al., 1998, 2001; Winnier et al., 1999) and that
compound Foxc1+/−; Foxc2−/− mutants have a failure of the
OFT septation (Fig. 5J), we tested whether cell behavior of
migrating NCCs is affected in compound Foxcmutants at E9.25
(Fig. 3). The expression domains of AP2α, a marker for
migrating NCCs, were not significantly altered in compound
Foxc1+/−; Foxc2−/− and Foxc1−/−; Foxc2−/− mutants (Figs. 3B,
C, E, F), compared to wild-type embryos (Fig. 3A), suggesting
that Foxc genes are not required for the initial migration of
NCCs. However, compound Foxc1+/−; Foxc2−/− mutants had
the hypoplastic second pharyngeal arches (Fig. 3B) and
compound homozygotes lack both the first and second
pharyngeal arches (Fig. 3C) (Kume et al., 2001). Significantly,
TUNEL analysis revealed that the domains of AP2α expression
were overlapped with TUNEL-positive apoptotic cells in
compound Foxc1+/−; Foxc2−/− and Foxc1−/−; Foxc2−/− mutants
(Figs. 3B, C, E, F), indicating that NCCs have increased
apoptosis during their migration.
Compound Foxc1+/−; Foxc2−/− mutants have reduced
contribution of cardiac NCCs to the OFT
A subpopulation of cardiac NCCs migrates into the OFT
cushions as early as E10.5 (Gitler et al., 2003b). Given that
Foxc mutant NCCs underwent apoptosis (Figs. 3B, C, E, F)
and compound Foxc1+/−; Foxc2−/− mutants had defects in
the OFT septation (Fig. 5J), we next examined the
contribution of cardiac NCCs to the OFT in compound
Foxc1+/−; Foxc2−/− mutants at E10.5 and E11.5. PlexinA2 is
expressed in the migrating NCCs and postmigratory NCCs
(cushion mesenchyme) in the OFT (Brown et al., 2001) (Figs.
4A, C, E). In compound Foxc1+/−; Foxc2−/− mutants, the
number of PlexinA2-expressing NCCs was significantly
reduced in the OFT cushion at E10.5 (Fig. 4B). At E11.5,
while wild-type embryos formed the septation with condensed
NCCs (Figs. 4C, E), compound Foxc1+/−; Foxc2−/− mutants
showed diffuse distribution of NCCs with no obvious
septation in the OFT (Figs. 4D, F). As shown in Figs. 4H
and J, in compound Foxc1+/−; Foxc2−/− mutants, PlexinA2-
expressing NCCs underwent apoptosis in the aortic sac
region, while no obvious apoptosis was observed in the OFT
cushions. It should be noted that the articopulmonary septum
was also absent in compound Foxc1+/−; Foxc2−/− mutants
(Fig. 4J). These results suggest that, in compound Foxc1+/−;
Foxc2−/− mutants, a small number of cardiac NCCs migrate
into the OFT and they fail to condense, leading to the lack of
the OFT septation.
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Fig. 3. Increased apoptosis of migrating NCCs in compound Foxc1; Foxc2mutants. (A–F) Immunohistochemical analysis for the neural-crest/ectoderm marker AP2α
(green) and apoptosis (TUNEL, red) on transverse sections through the first and second pharyngeal arches (PA I–II), and third PA and aortic sac (PA III/AS) at E9.25
(somites 20–22). Similar to the wild-type (A and D), AP2α protein appears to be unaltered in compound Foxc1+/−; Foxc2−/− (B and E) and Foxc1−/−; Foxc2−/− (C and
F) mutants. NCCs double-positive for AP2α/TUNEL (yellow) are undergoing apoptosis. Notably, AP2α-positive NCCs underwent increased apoptosis in compound
Foxc1+/−; Foxc2−/− (B and E) and Foxc1−/−; Foxc2−/− mutant (C and F). AS; aortic sac; g, foregut; OV, otic vesicle. Scale bars, 100 µm.
427S. Seo, T. Kume / Developmental Biology 296 (2006) 421–436We next examined whether smooth muscle differentiation in
the OFT is affected in compound Foxc1+/−; Foxc2−/− mutants.
SM22α expression is observed in the condensing cushion
mesenchyme of the distal OFT of wild-type embryos (Figs. 4K,
M, O), and these cells also express PlexinA2 (Figs. 4A, C, E),
indicating their neural crest origin (Li et al., 2005). Transcripts
of SM22α are also detected in the myocardium of the OFT at
this stage. As in the case of PlexinA2 expression, in compoundFig. 2. Downregulation of marker gene expression in the second heart field of compou
embryos at the cardiac crescent stage (E7.75). The expression domains of the second h
a large extent, with those of Foxc1 (D) and Foxc2 (E). Note overlapping expression of
on transverse sections of wild-type and compound Foxc1; Foxc2 mutant embryos
splanchnic mesoderm (arrowheads) in compound Foxc1+/−; Foxc2−/− (H) and Foxc
downregulated in the pharyngeal mesoderm (arrows) as well as splanchnic mesoderm
mutants. (M–O) Tbx1 expression was absent in the pharyngeal mesoderm (arrows) an
Foxc1−/−; Foxc2−/− (O) mutants. (P–R) Unlike Fgf8, Fgf10, and Tbx1, transcripts of
mesoderm (arrowheads) in compound Foxc1+/−; Foxc2−/− (Q) and Foxc1−/−; Fox
pharyngeal mesoderm (arrows), whereas those in the splanchnic mesoderm (arrow
Foxc1−/−; Foxc2−/− (R) mutants. Red arrows indicate the endoderm. (S–X) Radioac
heart field and OFT at E10.5. In the compound Foxc1+/−; Foxc2−/− mutant, Isl1 (
second heart field (arrows), and also restricted to the caudal region (arrowheads)
myocardium of the mutant (X, arrowhead). (Y–Z) Immunohistochemical analysis a
the anterior part of the second heart field. The merged image (yellow) of BrdU/Isl1
positive cells in the anterior part of the second heart field of the mutant (Z, arrowFoxc1+/−; Foxc2−/− mutants (Figs. 4L, N, P), SM22α expres-
sion was present but reduced and diffuse at E10.5 and E11.5.
Similarly, the transcription of SM22α was also reduced in the
myocardium of the OFT in compound Foxc1+/−; Foxc2−/−
mutants. Taken together, these data suggest that although
cardiac NCCs are able to differentiate into the smooth muscle in
the OFT, they fail to condense and divide the OFT into the aorta
and pulmonary trunk.nd Foxc1; Foxc2mutants. (A–F)Whole-mount in situ hybridization of wild-type
eart field markers, Isl1 (red arrow; A), Fgf10 (B), and Tbx1 (C) are overlapped, to
Foxc1 (brown red) with Isl (purple) (F). (G–R) Radioactive in situ hybridization
at E8.5 (8 somites). (G–L) Fgf8 expression (G–I) was downregulated in the
1−/−; Foxc2−/− (I) mutants, while expression of Fgf10 (J–L) was significantly
(arrowheads) in compound Foxc1+/−; Foxc2−/− (K) and Foxc1−/−; Foxc2−/− (L)
d splanchnic mesoderm (arrowheads) in compound Foxc1+/−; Foxc2−/− (N) and
Isl1 were slightly reduced in the pharyngeal mesoderm (arrows) and splanchnic
c2−/− (R) mutants. Note a dose-dependent decrease in Isl1 transcripts in the
heads) were partially reduced in both compound Foxc1+/−; Foxc2−/− (Q) and
tive in situ hybridization on sagittal sections at the anterior part of the second
T) and Bmp4 (V) transcripts were partially reduced in the anterior part of the
of the OFT myocardium. But, Bmp7 transcripts were not altered in the OFT
t E10.5 to detect BrdU-positive cells within the Isl1-positive cell population of
shows that BrdU-positive cells were reduced, consistent with reduction of Isl1-
). Scale bars, 100 µm.
Fig. 4. Compound Foxc1+/−; Foxc2−/− mutants have reduced contribution of NCCs to the OFT. (A–F) Radioactive in situ hybridization for the neural crest marker
PlexinA2 on sagittal (A and B), transverse (C and D), and coronal (E and F) sections at E10.5 (A and B) and E11.5 (C–F). The expression of PlexinA2 was reduced in
the OFT cushion (arrows) of compound Foxc1+/−; Foxc2−/− mutant (B and D). In contrast to the wild-type with the focal and dense distribution of NCCs (E, arrows),
compound Foxc1+/−; Foxc2−/− mutant had diffusive localization of PlexinA2-positive cardiac NCCs (F, arrows). (G–J) TUNEL assay on adjacent sections (A–B vs.
G–H; E–F vs. I–J) revealed that PlexinA2 expressing NCCs underwent apoptosis in the aortic sac region (H, dashed box and inlet), but not in the OFT cushion (H and
J) of compound Foxc1+/−; Foxc2−/−mutants. High magnification view of dashed box in H) was shown in the inlet. (K–P) Radioactive in situ hybridization analysis for
the smooth muscle differentiation marker SM22α on sagittal (K–L), transverse (M–N), and coronal (O–P) sections of the OFT at E10.5 (K and L) and E11.5 (M–P).
The expression of SM22α was significantly reduced in the distal OFT cushion mesenchyme (arrows) as well as the OFT myocardium (arrowheads) of compound
Foxc1+/−; Foxc2−/−mutants (L and N). It should to be noted that compound Foxc1+/−; Foxc2−/−mutant had the lack of proximal OFT (H, see Figs. 1O and Q). SM22α
expression was diffused in the distal OFT cushion (arrows) of compound Foxc1+/−; Foxc2−/− mutant (P) at E11.5, compared with the wild-type (O). AS, aortic sac;
AO, aorta; dOFT, distal outflow tract; pOFT, proximal outflow tract; PT, pulmonary trunk. Scale bars, 100 µm.
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formation of the endocardial cushions and septation
In addition to cardiac NCCs, the Foxc genes are expressed in
the endocardial cells and endocardial cushions (Supplementary
Fig. 3) (Kume et al., 1998; Winnier et al., 1999). It is known that
the endocardial cushion mesenchyme of the OFT is composed
of endocardial and cardiac NCC-derivatives (de Lange et al.,
2004; Jiang et al., 2000). EMT in the OFT begins in the
endocardium around E9.5, while at E10.5 cardiac NCCs reach
to the distal OFT and further migrate into the proximal OFT,thereby leading to the significant increase of endocardial
cushion swellings from E11.5 to E13.5 (Epstein et al., 2000;
Gitler et al., 2003a,b). Cardiac NCCs initially separate the distal
cushion of the OFT into the aorta and pulmonary trunk
(aorticopulmonary septum) (Jiang et al., 2000), while the
proximal OFT cushions contribute to an embryonic outlet
septum within the right ventricle (Webb et al., 2003). We found
that compound Foxc1+/−; Foxc2−/− mutants had a sparse
distribution of the cushion mesenchyme in the OFT at E10.5
(Figs. 5B, D) in contrast to the wild type with the swelling of the
distal OFT cushions (Figs. 5A, C). At 11.5, although wild-type
Fig. 5. Defects in the endocardial cushions and OFT septation in compound Foxc1+/−; Foxc2−/− mutants. (A–F) Histological analysis of the OFT (A–D) and
atrioventricular (AV) cushions (E–F) in wild-type (A, C, and E) and compound Foxc1+/−; Foxc2−/− mutant (B, D and F) embryos at E10.5. Compound Foxc1+/−;
Foxc2−/−mutant had hypoplasia of the OFTcushion and aorticopulmonary septum (red arrow) (B), compared with the wild-type (A). High magnification views (C and
D) of the OFT cushions in the panels A and B (boxes) show reduced cell density of the OFT cushion mesenchyme in compound Foxc1+/−; Foxc2−/− mutant (D),
compared with wild-type embryo (C). Compound Foxc1+/−; Foxc2−/−mutant also had hypoplastic AV cushions (F). (G–L) Histological analysis of the OFT (G–J) and
AV (K and L) cushions in wild-type (G, I, and K) and compound Foxc1+/−; Foxc2−/− mutant (H, J, and L) embryos at E11.5. Compound Foxc1+/−; Foxc2−/− mutant
had no septation with a straight and common OFT in which the cushion mesenchyme was significantly reduced and diffusively distributed (H, J), compared to the OFT
septation with spiraled and condensed mesenchyme (arrows) in wild-type embryo (G and I). Compound Foxc1+/−; Foxc2−/−mutant had no obvious mesenchyme-free
zones (J, boxes), compared with those of wild-type embryo (I). Compound Foxc1+/−; Foxc2−/− mutant also had hypoplastic AV cushion formation with reduced cell
density of the mesenchyme (L). AS, aortic sac; AVC, atrioventricular canal; LV, left ventricle; PT, pulmonary trunk; RV, right ventricle; T, trabeculated myocardium.
Scale bars, 100 mm.
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aorta and pulmonary trunk (Figs. 5G, I), compound Foxc1+/−;
Foxc2−/− mutants had a reduction of mesenchymal cell density
in the endocardial cushions (Figs. 5H, J), resulting in failure of
OFT septation. In compound Foxc1+/−; Foxc2−/− mutants, the
OFT mesenchyme was symmetrically distributed with no
mesenchyme-free region (Fig. 5J), suggesting that compound
Foxc1+/−; Foxc2−/− mutants fail to establish defined cushions.
Interestingly, since there was not only a decrease in cellularity,
but also a loss of the three-dimensional cushion structure, the
cushion regions in compound Foxc1+/−; Foxc2−/− mutants
were not properly restricted from the surrounding tissues.
The cushion mesenchyme of the atrioventricular (AV) canal
is thought to be derived largely from the endocardium and, to
some extent, from EPDCs through EMT (Gittenberger-de Groot
et al., 1998; Kisanuki et al., 2001). Interestingly, compound
Foxc1+/−; Foxc2−/− mutants displayed hypoplasia of the AV
cushion mesenchyme and AV canal (Figs. 5F, L) with reduced
cell density, resulting in lack of morphologically distinct
cushions. Taken together, these results suggest that compoundmutants for Foxc1 and Foxc2 form the endocardial cushions of
the OFT and AV canal, but their development is impaired.
Compound Foxc1+/−; Foxc2−/− mutants have reduced cell
proliferation in the endocardial cushions of the OFT and AV
canal
The observation of hypoplasia of the OFT and RVas well as
endocardial cushions of the OFT and AV canal in compound
Foxc mutants led us to examine cell proliferation in the heart
of these mutants at E10.5 and E11.5. Interestingly, cell
proliferation in the OFT myocardium of compound Foxc1+/−;
Foxc2−/− mutants was significantly reduced at E10.5 (Figs. 6B,
I), but not at E11.5 (Figs. 6D, I), suggesting that the addition of
myocardial cells from the second heart field at E10.5 is impaired
in compound Foxc1+/−; Foxc2−/− mutants. This is consistent
with a reduced cell proliferation in the Isl1-expressing cells in
these mutants at E10.5 (Fig. 2Z). Moreover, we found a
significant reduction of cell proliferation in the OFT and AV
cushions in compound Foxc1+/−; Foxc2−/− mutants at both
430 S. Seo, T. Kume / Developmental Biology 296 (2006) 421–436E10.5 and E11.5 (Figs. 6B, D, F, I). By contrast, TUNEL assays
showed that apoptosis in the OFTand AV cushions in compound
Foxc1+/−; Foxc2−/− mutants was comparable with that of wild-
type embryos (Supplementary Fig. 2), suggesting that the
hypoplastic OFTand AV cushions observed in these mutants are
mainly associated with a significant reduction of cell prolifera-tion. Consistent with this observation, we have found decreased
expression of cushion markers such as Bmp2/4 and Msx1/2 in
compound Foxc1+/−; Foxc2−/− mutants (Supplementary Fig. 5).
Cell proliferation in the ventricular myocardium of com-
pound Foxc1+/−; Foxc2−/− mutants at E11.5 was significantly
reduced in the trabecular zone, but not in the compact
431S. Seo, T. Kume / Developmental Biology 296 (2006) 421–436myocardium (Figs. 6H, I). Although the trabeculae were
initially formed in these mutants at E9.0 (Fig. 1H), the
trabeculated myocardium was severely disorganized at E11.5
(Fig. 5H). The ventricular trabeculation, which plays a crucial
role in maintaining the blood flow, develops from E9.0 to E13.5
through reciprocal interactions between the myocardium and
endocardium (Brutsaert, 2003). Given that Foxc genes are
expressed in endocardial cells, but not in myocardial cells
(Supplementary Fig. 3) (Kume et al., 1998; Winnier et al.,
1999), the disorganized trabeculation in compound Foxc1+/−;
Foxc2−/− mutants may be partly due to dysfunction of
endocardial cells.
Compound Foxc1+/−; Foxc2−/− mutants have abnormal
formation of the epicardium
In the course of analysis of the hearts of compound Foxc1+/−;
Foxc2−/− mutants, we observed abnormal formation of the
epicardium at the conoventricular junction at E10.5 (5/10) and
E11.5 (7/7) (Figs. 7B, D), while single mutants and compound
Foxc1−/−; Foxc2+/− mutants formed the epicardium normally
(data not shown). Most interestingly, in compound Foxc1+/−;
Foxc2−/− mutants at E11.5, the epicardium in this region
became distended and detached from the underlying myocar-
dium (Fig. 7D), with a population of mesenchyme-like cells
proliferating within the enlarged subepicardial space (Fig. 7F).
WT-1 is expressed specifically in the PE, epicardium, and
subepicardial mesenchyme (Moore et al., 1999; Perez-Pomares
et al., 2002b). WT-1 positive cells are detected in the
mesenchyme within the subepicardial space of compound
Foxc1+/−; Foxc2−/− mutants (Fig. 7H), suggesting that they are
derived from the epicardium by EMT. Interestingly, immunos-
taining of makers for smooth muscle and endothelial cells (α-
SMA and PECAM-1) revealed that, in the subepicardium of
compound Foxc mutants, some of these mesenchymal cells,
likely derived from the epicardium, already differentiated into
smooth muscle and endothelial cells, respectively (Figs. 7J, L).
These data suggest that lack of Foxc genes leads to an
accelerated process of EMT at the conoventricular junction of
the epicardium.
Discussion
The formation of the heart during development requires a
complicated series of morphogenetic interactions involvingFig. 6. Cell proliferation defects in the endocardial cushions and myocardium of comp
incorporation assays in the OFT (A–D) and AV cushions (E and F), and the ventricula
Foxc2−/− mutant (B, D, F, and H) embryos. Sections were counterstained with he
compound Foxc1+/−; Foxc2−/−mutant had a significant decrease in the number of Brd
(B), compared with wild-type embryo (A). (C–H) At E11.5, compound Foxc1+/−; F
cushions of the OFT (D) and AV canal (F) as well as the trabeculated myocardium (H
in the OFT myocardium and the compact zone (boxes) of the ventricle myocardium be
embryos. (I) Quantification of BrdU-positive cells in wild-type and compound Fox
Foxc2−/− mutants, cell proliferation was significantly reduced in the OFT and AV c
myocardium (E11.5). Data were collected from three embryos per genotype and prese
of P < 0.05 was considered statistically significant between wild-type and mutants, as
compact myocardium; Tra, trabeculated myocardium. Scale bars, 100 μm.cells of several embryonic origins. In spite of exciting
progress in identifying signaling factors involved in heart
morphogenesis, a great deal remains to be learned about
molecular and cellular mechanisms underlying the etiology of
congenital heart abnormalities in humans. In this paper, we
demonstrate that compound Foxc1; Foxc2 mutant embryos
exhibit multiple defects in the developing heart, including
hypoplasia of the OFT and RV as well as the IFT. These
abnormalities are likely to reflect the broad expression pattern
of Foxc genes in cardiac and extracardiac cell populations
during heart development. Thus, the cardiac phenotype of
compound Foxc1/c2 mutant reported here provides new
genetic insights into the complex processes of early heart
development.
Foxc1 and Foxc2 regulate the developmental process in the
second heart field
It has recently been demonstrated that the OFT, RV, and part
of the atrium and IFT are derived from a second cell lineage,
which encompass the anterior or secondary heart field (AHF or
SHF) (Cai et al., 2003; Kelly, 2005; Meilhac et al., 2004), and a
growing number of transcription factors and signaling mole-
cules have been implicated in this newly identified subpopula-
tion in the cardiac progenitors (Buckingham et al., 2005; Kelly,
2005). These include transcription factors Tbx1 (Yamagishi et
al., 2003), Isl1 (Cai et al., 2003), Foxh1 (von Both et al., 2004),
and Mef2c (Dodou et al., 2004), as well as signaling molecules
such as Fgf8 and Fgf10 (Buckingham et al., 2005; Kelly, 2005).
The perturbation of these genes in the second heart field
commonly leads to severe OFT defects, although obvious
cardiac defects are not observed in Fgf10 null mutants (Sekine
et al., 1999) possibly due to the compensation by other FGFs
(e.g. FGF8).
In this work, we found that formation of the OFT, RV, and
IFT was severely impaired in compound Foxc1+/−; Foxc2−/−
and Foxc1−/−; Foxc2−/− mutant embryos (Fig. 1), while
compound Foxc1−/−; Foxc2+/− mutants did not appear to have
such abnormalities (data not shown). Although further compar-
ison of the spatiotemporal expression patterns of Foxc1 and
Foxc2 in the second heart field needs to be performed, we
have recently found that Foxc2 has stronger transcriptional
activity in the cardiovascular system than Foxc1 (Fujita et al.,
2006; Seo et al., 2006), suggesting the functional differences
between the two genes.ound Foxc1+/−; Foxc2−/−mutants. (A–H) Cell proliferation determined by BrdU
r myocardium (G and H) in wild-type (A, C, E, and G) and compound Foxc1+/−;
matoxylin, and BrdU-positive signals are shown in brown. (A–B) At E10.5,
U-positive cells in the endocardial cushion and myocardium (boxes) of the OFT
oxc2−/− mutants had the reduction in the BrdU-positive cells in the endocardial
). However, no obvious difference in the number of BrdU-positive cells was seen
tween wild-type (C and G) and compound Foxc1+/−; Foxc2−/−mutant (D and H)
c1+/−; Foxc2−/− mutant embryos at E10.5 and E11.5. In compound Foxc1+/−;
ushions (E10.5 and E11.5), the OFT myocardium (E10.5), and the trabeculated
nted by mean ± SEM. Statistical analyses were done by Student's t test. A value
indicated by asterisks (*). AV, atrioventricular cushion; OFT, outflow tract; Com,
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and Tbx1 in the splanchnic pharyngeal mesoderm of compound
Foxc mutants (Fig. 2). The lack of transcription factors Tbx1
(Hu et al., 2004; Xu et al., 2004), Isl1 (Cai et al., 2003), and
Foxh1 (von Both et al., 2004) leads to similar reduction of
Fgf8 and Fgf10 expression in this region, thereby regulating
cell proliferation and survival. Importantly, Fox proteinsregulate the expression of Tbx1 in the second heart field
through a combination of two Fox binding sites in a dose-
dependent manner (Maeda et al., 2006). Consistent with these
observations, compound Foxc1/c2mutants also had the reduced
proliferation in the OFT myocardium as well as the anterior
portion of the second heart field (Figs. 2Z and 6I). Interestingly,
however, Isl1 expression in compound Foxc mutants was
slightly reduced, but still remained in the splanchnic mesoderm
(E8.5) and the second heart field (E10.5) (Figs. 2R, T). We
cannot exclude the possibility that the decreased Isl1 expression
in compound Foxc1; Foxc2mutants may result from a reduction
in cell proliferation in these regions, thereby failing to expand
Isl1-expressing progenitors. Compared to the phenotypes of
mutant embryos for Tbx1 and Fgf8/10, the lack of the OFT, RV,
and IFT in compound Foxc1−/−; Foxc2−/− mutants is, to some
extent, similar to those seen in Isl1 homozygous null mutants
(Cai et al., 2003). However, the functional interaction between
Isl1 and Foxc in the second heart field is still unclear. For
example, unlike Isl1 mutant embryos, expression levels of
Bmp4/7 were not greatly reduced in compound Foxc mutants
(Figs. 2V, X). Since we have recently shown that Foxc1 and
Foxc2 can bind to Smad4 (Fujita et al., 2006), it is possible that
they act as transcriptional components of BMP signalling in the
second heart field. Taken together, Foxc genes are likely to act
upstream of the Tbx1-FGF cascade paralleling Isl1, as recently
proposed (Buckingham et al., 2005).
Ablation of the cardiac neural crest in the chick leads to
failure of addition of the definitive OFT myocardium from the
second heart field (Yelbuz et al., 2002, 2003). Foxc genes are
also expressed in the cardiac NCCs (Winnier et al., 1999) and
we show that Foxc mutant NCCs had increased apoptosis
leading to the absence of OFT septation. We found a cell
proliferation defect in the OFT myocardium in compound
Foxc1+/−; Foxc2−/− mutants at E10.5, which is possibly due to
two defective cell populations, the second heart field-derivedFig. 7. Abnormal formation of the epicardium in compound Foxc1+/−; Foxc2−/−
mutants. (A–D) Histological analysis of the epicardium at the conoventricular
junction of wild-type (A and C) and compound Foxc1+/−; Foxc2−/− mutant (B
and D) embryos at E10.5 (A and B) and E11.5 (C and D). Compound Foxc1+/−;
Foxc2−/− mutants had the abnormally detached epicardium (arrows) separating
from the myocardium (B and D). Note a large number of mesenchymal cells
present within the subepicardial space (boxed region) in the mutant (D). (E–L)
Immunohistochemical analysis at the conoventricular region of wild-type (E, G,
I, and K) and compound Foxc1+/−: Foxc2−/− mutant (F, H, J, and L) embryos at
E11.5. (E–F) Cell proliferation assay in the subepicardial mesenchyme. In
compound Foxc1+/−; Foxc2−/− mutant, BrdU-positive cells (arrowheads) were
observed (F). Arrows indicate the epicardium. (G–H) Immunostaining forWT-1.
Some of the mesenchymal cells expressed WT-1 (arrowheads) within the
subepicardial space of compound Foxc1+/−; Foxc2−/− mutant (H). Arrows
indicate the epicardium positive for WT-1. (I–J) Immunostaining for α-SMA. In
compound Foxc1+/−; Foxc2−/− mutant (J), α-SMA positive cells (arrowheads)
were observed within the subepicardial space. Note that α-SMAwas not detected
in the epicardium (arrows). (K–L) Immunostaining for PECAM-1. Although
there were no PECAM-1 positive cells in the subepicardial space of the wild type
(K), expression of PECAM-1was detected in the subepicardial mesenchyme (red
arrow) in compound Foxc1+/−; Foxc2−/− mutant (L). Arrows indicate the
epicardium. OFT, outflow tract; RV, right ventricle; LV, left ventricle. Scale bars,
100 μm.
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that significant cardiac defects in compound Foxc1; Foxc2
mutants, including the abnormal morphology of the developing
OFT and reduced expression of Tbx1 and Fgf8/10, can be
detected as early as E8.5, prior to the arrival of NCCs to the
OFT. Therefore, although we cannot rule out the possibility of
the noncell autonomous effect of cardiac NCCs on the
derivatives of the anterior portion of the second heart field in
compound Foxc mutants, the phenotype of the OFT is likely
cell autonomous.
Involvement of Foxc in cardiac NCCs in heart development
In line with extensive apoptosis in NCCs of compound
Foxc1+/−; Foxc2−/− mutants, compound Foxc1+/−; Foxc2−/−
mutants at E11.5 showed reduced condensation with diffused
localization of NCC-derived mesenchymal cells in the OFT,
leading to the failure of the OFT septation and persistent truncus
arteriosus (PTA). Although we still cannot rule out the
possibility of the decreased expression of PlexinA2 and
SM22α in these cells in the OFT, the number of mutant NCCs
in the OFT is likely to be reduced. In addition, it should be noted
that Foxc1 and Foxc2 are expressed in the endocardium. Thus,
in addition to cardiac NCCs, lack of Foxc genes in the
endocardium may affect the formation of OFT cushions. We
also found that, in compound Foxc mutants, SM22α expression
in the myocardium of the OFT is reduced. A recent quail-to-
chick chimera study showed that the SHF contributes to the
smooth muscle of the proximal OFT adjacent to the primary
heart field-derived OFT myocardium (Waldo et al., 2005b).
However, the localization of the equivalent cell population in
the mouse embryo is unknown.
We have previously reported that compound Foxc1+/−;
Foxc2−/− mutants show lack of the 2nd pharyngeal arch and
hyoplastic 3rd and 4th pharyngeal arches at E10.5 (Kume et al.,
2001). Hypomorphic Fgf8 mutants display the disruption of the
3rd and 4th pharyngeal arches and increased apoptosis of NCCs
which migrate through pharyngeal arches to the OFT (Abu-Issa
et al., 2002; Frank et al., 2002). Moreover, similar defects are
observed in conditional mutants for Fgf8 in the pharyngeal
ectoderm (Macatee et al., 2003), implying that the Fgf8 signal
from the ectoderm regulates the survival of NCCs. Therefore, it
is possible that Foxc mutant NCCs cannot respond to this
signal. It has been shown that Shh signaling acts upstream of
Foxc2 regulating Tbx1 expression in the head mesenchyme
(Yamagishi et al., 2003) and that the Shh-Fox cascade has been
implicated in cranial NCC development (Jeong et al., 2004). Of
note, the OFT phenotype seen in Shh homozygous mutants are
similar to those seen in compound Foxc mutants (Washington
Smoak et al., 2005). Although the authors conclude that the Shh
signaling pathway is not directly involved in the survival of
NCCs, it is interesting to further test the interaction of Foxc with
the Shh pathway.
We cannot exclude the possibility that the surrounding
tissues including the head mesenchyme affect cell behavior (e.g.
cell proliferation and survival) of migrating NCCs in compound
Foxc mutants. Indeed, Foxc genes are transcribed in thecephalic mesoderm, and apoptosis was also detected in its
derivatives in compound Foxcmutants. In order to elucidate the
precise role of Foxc in cardiovascular development, conditional
ablation of Foxc genes in specific tissues such as the cardiac
NCCs and the second heart field needs to be performed in the
future.
The role of Foxc in epicardial development
The epicardium originating from the PE plays an essential
role in coronary vessel formation by providing a source of
vascular smooth muscle and endothelial cells (Manner et al.,
2001; Olivey et al., 2004). A recent study also showed that the
epicardium of the distal OFT originates from the cephalic
pericardium near the aortic sac, while that of the proximal OFT
is derived from the PE, suggesting the presence of two distinct
epicardial origins of the OFT (Perez-Pomares et al., 2003).
Both Foxc1 and Foxc2 are expressed in a subset of cells in
the PE at E9.0 (18–20 somites), as confirmed by the expression
of PE markers Capsulin1 (Lu et al., 1998) and WT-1 (Moore et
al., 1999) (Supplementary Fig. 5), while transcripts of Foxc are
not detected in the developing epicardium (data not shown). We
show in this paper that compound Foxc1+/−; Foxc2−/− mutants
had abnormal epicardium as early as E10.5 (Fig. 7). Although
the epicardially derived mesenchymal cells are generated at the
entire region of the heart through EMT of the epicardium, the
majority of these cells are produced at the atrioventricular
junction (Poelmann et al., 2002; Wessels and Perez-Pomares,
2004). Thus, it is quite intriguing that a massive amount of
mesenchymal cells were particularly observed at the sub-
epicardial space of the conoventricular region in compound
Foxc1+/−; Foxc2−/− mutants. Furthermore, some of these cells
appeared to differentiate into either smooth muscle or endothe-
lial lineage, although it is not clear whether they are derived from
the epicardium of compound Foxc mutants.
FOG-2 homozygous mutants lack the subepicardial
mesenchyme, providing evidence that the signal(s) from the
myocardium are important for the initiation of EMT in the
epicardium (Tevosian et al., 2000). Several molecular signals
such as VEGF, FGF, and TGFβ have been found to be
associated with the regulation of epicardial EMT (Morabito et
al., 2001; Olivey et al., 2004, 2006). Given the OFT defects
observed in compound Foxc1+/−; Foxc2−/− mutants, one
possibility is that accelerated EMT results from dysregulation
of myocardially derived signaling molecules. Another non-
exclusive possibility is that compound Foxcmutants may fail to
establish proper cell–cell interactions between the myocardium
and epicardium. Further studies are required to elucidate the
nature of epicardial defects in compound Foxc mutants.
Implications for human congenital heart defects associated
with mutations of FOXC genes
Severe developmental defects of the OFT are tolerated
during embryonic development, but are lethal in post-natal life,
because the pulmonary circulation is required for blood
oxygenation. Whereas congenital heart disease is the most
434 S. Seo, T. Kume / Developmental Biology 296 (2006) 421–436common of all birth defects (Hoffman and Kaplan, 2002),
developmental defects in the OFT account for a high proportion
of these disease cases, leading to a major cause of morbidity and
mortality in children. In particular, chromosome 22q11.2
deletion (del22q11) causes most cases of DiGeorge syndrome,
velocardiofacial syndrome, and conotruncal anomaly face
syndrome, and it is one of the most common genetic causes
of OFT and aortic arch defects. The identification of Tbx1 as a
critical gene of the del22q11 syndrome has led to significant
progress in revealing complex networks of signaling and
transcriptional events in cardiovascular development (Baldini,
2004; Yagi et al., 2003; Yamagishi and Srivastava, 2003).
There is some evidence that humans heterozygous for
mutations in FOXC1, associated with the dominantly inherited
Axenfeld–Rieger anomaly, have congenital heart defects such
as mitral valve dysplasia and atrial septal defects (Honkanen et
al., 2003; Mears et al., 1998; Winnier et al., 1999). Mutations in
human FOXC2 are responsible for the autosomal dominant
syndrome, lymphedema-distichiasis, and, importantly, it has
been reported that ∼ 15% of these humans have conotruncal
cardiac defects (Fang et al., 2000). Therefore, although the
etiology and molecular mechanisms underlying conotruncal
anomalies still remain to be elucidated, the observed genetic
interactions in this paper will have significant implications for
the possible interaction of mutations causing cardiovascular
defects in heterogeneous human populations. In particular,
studies on further understanding how Foxc1 and Foxc2 function
in the process of early heart development will be an important
goal to elucidate the etiology of congenital anomalies, including
DiGeorge syndrome.
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